Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenkre

Showing results (251-260 of 288) with videos related to

Pageof 29
Sort By:
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Diabetes Care|June 10, 2019
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled StudyPreeshila Behary, George Tharakan, Kleopatra Alexiadou, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Blood Cancer Journal|March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapyReem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C Rutherford, Jun Yin, Levi Pederson, et al.
BMJ Open Diabetes Research & Care|January 7, 2021
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitalsChioma Izzi-Engbeaya, Walter Distaso, Anjali Amin, et al.
Cancers|July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CARTNicole J Altomare, Megan M Herr, Nisha M Nair, et al.
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Blood Advances|October 22, 2025
Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortiumMegan Melody, Natalie Grover, Stephanie Franco, et al.
American Journal of Hematology|January 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Michael A Spinner, Kevin David, et al.
Pageof 29

Showing results (251-260 of 288) with videos related to

Sort By:
Pageof 29
Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.
Diabetes Care|June 10, 2019
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled StudyPreeshila Behary, George Tharakan, Kleopatra Alexiadou, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Blood Cancer Journal|March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapyReem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C Rutherford, Jun Yin, Levi Pederson, et al.
BMJ Open Diabetes Research & Care|January 7, 2021
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitalsChioma Izzi-Engbeaya, Walter Distaso, Anjali Amin, et al.
Cancers|July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CARTNicole J Altomare, Megan M Herr, Nisha M Nair, et al.
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Blood Advances|October 22, 2025
Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortiumMegan Melody, Natalie Grover, Stephanie Franco, et al.
American Journal of Hematology|January 11, 2023
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphomaSanjal H Desai, Michael A Spinner, Kevin David, et al.
Pageof 29